Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADHD
MedTech
FDA clears Lumosity brain training games for adult ADHD
Dubbed LumosityRx, the agency's 510(k) covers the smartphone app's use in improving attention among people between the ages of 22 and 55.
Joseph Keenan
Dec 11, 2025 10:00am
Akili cuts workforce another 40%, eyes OTC digital app model
Sep 14, 2023 10:35am
Akili's video game ADHD treatment now available for adults
Jun 7, 2023 3:05pm
Akili aims to expand its videogame ADHD treatment to adults
May 3, 2023 1:00pm
Akili axes 46 workers, slims prescription video game pipeline
Jan 17, 2023 10:40am
In struggling Vallon, GRI Bio spots opportunity to reach Nasdaq
Dec 14, 2022 8:27am
